4127 Stock Overview
Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Tien Liang BioTech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$30.35 |
| 52 Week High | NT$41.00 |
| 52 Week Low | NT$13.25 |
| Beta | 0.74 |
| 1 Month Change | 11.99% |
| 3 Month Change | 115.25% |
| 1 Year Change | 97.72% |
| 3 Year Change | 187.68% |
| 5 Year Change | 189.05% |
| Change since IPO | 35.68% |
Recent News & Updates
Shareholder Returns
| 4127 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | -21.4% | -2.2% | -1.6% |
| 1Y | 97.7% | 7.2% | 25.9% |
Return vs Industry: 4127 exceeded the TW Pharmaceuticals industry which returned 7.2% over the past year.
Return vs Market: 4127 exceeded the TW Market which returned 25.9% over the past year.
Price Volatility
| 4127 volatility | |
|---|---|
| 4127 Average Weekly Movement | 10.7% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.6% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 4127's share price has been volatile over the past 3 months.
Volatility Over Time: 4127's weekly volatility has increased from 6% to 11% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1960 | 65 | Min-Chung Chi | www.tlb.com.tw |
Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, low back pain, sore feet, dizziness, thirst, dry tongue, sore throat, and heel pain, as well as rheumatism, joint pain, traveling pain, wind-cold-dampness, gout, neuralgia, enuresis, hemorrhoids, constipation, athlete’s foot, fall injuries, cold, bronchitis, cough, and phlegm indications. It provides western medicine products, including ointment, hair removal cream, tablet, capsule, soreness spray, and pain patch products, as well as pain relief gels.
Tien Liang BioTech Co., Ltd. Fundamentals Summary
| 4127 fundamental statistics | |
|---|---|
| Market cap | NT$1.39b |
| Earnings (TTM) | NT$17.73m |
| Revenue (TTM) | NT$459.99m |
78.3x
P/E Ratio3.0x
P/S RatioIs 4127 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4127 income statement (TTM) | |
|---|---|
| Revenue | NT$459.99m |
| Cost of Revenue | NT$173.85m |
| Gross Profit | NT$286.15m |
| Other Expenses | NT$268.42m |
| Earnings | NT$17.73m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.39 |
| Gross Margin | 62.21% |
| Net Profit Margin | 3.85% |
| Debt/Equity Ratio | 14.2% |
How did 4127 perform over the long term?
See historical performance and comparison